Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2006

Conditions

Healthy

Interventions

DRUG

BILR 355 - Treatment A (current tablet formulation)

DRUG

BILR 355 - Treatment B (new tablet formulation)

DRUG

BILR 355 - Treatment C (new capsule formulation)

DRUG

BILR 355 - Treatment D (current tablet formulation)

DRUG

BILR 355 - Treatment E (new capsule formulation)

DRUG

Ritonavir